The traditionally lucrative life sciences sector is facing rapid change due to economic pressure, increasing regulations, competitiveness in OTC products, and the streamlining of public health systems. This context requires companies to redefine their operational strategies.

Companies in the sector must constantly improve the services they offer their customers, by developing new drugs and offering services tailored to patients and prescribers. Digital plays a key role in meeting these needs. In addition, pharmaceutical companies must control the increasing costs of research and development while seeking industrial and distribution synergies.

To meet these challenges, pharmaceutical companies, as well as the entire life sciences sector, must constantly improve the quality of the services they offer their customers. This includes bringing new treatments to market and developing services for patients and prescribers, while exploiting the digital opportunities available.

In a context of sharply rising R&D costs, laboratories must optimize their efficiency by seeking industrial or distribution synergies. This requires rigorous management of post-acquisition integrations, particularly in the organizational, process and information systems areas. The support of a strategy consulting firm can be essential to successfully manage this complex management.

We support players in the life sciences sector in their transformation, by offering tailored solutions to improve performance across the entire operations chain:

• Operations Strategy:Managing the governance and organization of the supply chain and operations requires well-defined strategies for decision-making between internalization and outsourcing of activities, as well as optimization of the industrial network. Particular attention must be paid to simplifying the product catalog in order to reduce costs and improve efficiency.
• Digitalization: Real-time traceability through the Internet of Things (IoT) makes it possible to effectively monitor flows and transport, and to guarantee compliance with conditions, such as temperature compliance, while monitoring parallel markets.
• Cost control and economic performance: (Re)design to value makes it possible to maximize added value while optimizing costs, in particular through improved efficiency of the purchasing function and analysis of packaging costs (should-cost). Industrial competitiveness is enhanced by more precise resource management and inventory reduction, which optimizes operational costs.
• Organizational agility:New product development is part of a strategic approach to align planning with execution. This process involves seamless synchronization between sales, replenishment, production, and orders.
• Compliance with regulatory requirements:Change control management is crucial to ensure compliance and traceability of changes in industrial processes. This includes choosing the right serialization model, ensuring product safety while optimizing time to market.
• Intercompany collaboration:Controlling risks related to supply sources is essential to anticipate disruptions and secure the value chain, thus ensuring maximum continuity and reliability in product delivery.

Our firm combines deep technical expertise, hands-on operational management experience, and deep knowledge of the Life Sciences industry to help our clients overcome industry-specific challenges and achieve sustainable results. Our approach ensures engagement and collaboration at all levels of the organization, ensuring sustainable solutions and successful transformation. We’ve partnered with industry leaders like Medela, ThermoFisher Scientific, Incyte, and more.Click here to learn more.

Join the ranks of successful businesses we’ve helped.

Get in touch to learn how we can achieve the same results for you!